Today, however, many IRBs are run for profit,
creating an incentive to rule favorably on studies so that Cros won't take their business elsewhere.
In an effort to streamline operations and increase profit, the vast majority of pharmaceutical firms have outsourced their trials to third-party,
for-profit testing centers known as contract research organizations(Cros).